Niš, Serbia Health Recent News, Events and Opinion on Allvoices
Front Page

Just In Niš Health News

 
 
 
Source: Newswise

Niš :: Serbia | updated 2014-04-08 21:23:19 -0700 | health-news

Recent statistics taken from national administrative databases suggest that lumbar spinal fusion is on the rise, with the greatest increases occurring among patients with herniated discs or degenerative disc disease. Yet, surgeons claim neither condition is a well-accepted indication for...
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
 
Source: Globes Online

Niš :: Serbia | updated 2014-04-08 09:46:08 -0700 | health-news

Gabbay does not recommend nationalizing the hospital, as proposed by Ministry of Health director general Prof. Ronny Gamzo, recommending instead keeping it without a controlling core. Hadassah, Histadrut sign temporary labor agreement In effect, the Gabbay Committee recommends leaving the...
Credibility  
Views: 3   News Stories: 0
Blog Posts: 0 0 0 0
 
 
 
Source: Globes Online

Niš :: Serbia | updated 2014-04-03 13:37:16 -0700 | health-news

Let us mine Sde Barir, we'll invest NIS 600m In a letter to the director of the Planning Administration at the Ministry of the Interior, German said that after reading the reports and comments by the public health services, and...
Credibility  
Views: 1   News Stories: 1
Blog Posts: 0 0 0 0
 
 
Source: Novinite

Niš :: Serbia | updated 2014-03-25 05:46:01 -0700 | health-news

178 Comments: 0 Bulgarian citizens will be able to use the European Health Insurance Card on the territory of Serbia as of June 1, 2014...Healthcare will be provided by hospitals included in the network of medical facilities and by private...
Credibility  
Views: 1   News Stories: 0
Blog Posts: 0 0 0 0
 
 
Source: Globes Online

Niš :: Serbia | updated 2014-02-27 06:28:42 -0800 | health-news

The agreement is for RedHill's RHB-106 encapsulated formulation for bowel preparation and rights to other purgative developments for $7 million, plus $5 million in milestone payments. RedHill Biopharma raises $11.7m in private placement Orbimed invests $6m in RedHill Biopharma Salix...
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
 
Source: Globes Online

Niš :: Serbia | updated 2012-06-01 08:24:15 -0700 | business-news

Provigil, for the improvement of wakefullness, made by Teva's newest subsidiary, Cephalon Inc. Cephalon will produce both the generic and brand versions of Provigil at its US plant. Brand Provigil has $1.1 billion in annual US sales, according to IMS...
Credibility  
Views: 12   News Stories: 1
Blog Posts: 1 0 0 0
 
 
 
Source: Globes Online

Niš :: Serbia | updated 2012-03-29 10:35:39 -0700 | business-news

US subsidiary Cephalon has recalled a lot of its Treanda leukemia drug, because glass fragments were found in one of the vials. The US Food and Drug Administration (FDA) said in a statement that Cephalon distributed the Treanda lot TB30111...
Credibility  
Views: 18   News Stories: 1
Blog Posts: 0 2 1 0
 
 
Source: Globes Online

Niš :: Serbia | updated 2012-03-18 18:14:40 -0700 | business-news

Africa-Israel has made an offer to purchase for NIS 111 million at NIS 14.50 per share, a 24.5% premium over yesterday's closing price of NIS 11.64...Africa-Israel owns 73% of Danya Cebus and has offered to buy 7,673,827 of its shares,...
Credibility  
Views: 11   News Stories: 4
Blog Posts: 0 0 0 0
 
 
Source: Globes Online

Niš :: Serbia | updated 2012-02-26 14:37:58 -0800 | business-news

of a version of Itamar's EndoPAT diagnostic monitor for use on animals during preclinical trials. The EndoPAT, which is used by people, monitors the endothelial layer (the inner lining of blood vessels) to test for dysfunction, which is an early...
Credibility  
Views: 9   News Stories: 7
Blog Posts: 0 0 0 0
 
 
Source: Globes Online

Niš :: Serbia | updated 2012-02-14 10:56:47 -0800 | business-news

12, Hillel Koren   The shekel is weakening against the dollar but strengthening against the shekel in morning inter-bank trading today, after the US Federal Reserve Board kept its interest rate unchanged at 0-0.25%, and Federal Reserve Board Chairman Ben...
Credibility  
Views: 6   News Stories: 6
Blog Posts: 0 0 0 0
 
 
Source: Globes Online

Niš :: Serbia | updated 2012-02-13 14:48:53 -0800 | technology-news

Compugen for the treatment of a range of diseases, including acute and chronic inflammatory diseases, cardiac diseases, retinopathy, and cancer. Compugen will provide drug candidates, primarily peptides, which were identified using its predictive drug discovery platforms, and BioLineRx will...
Credibility  
Views: 4   News Stories: 4
Blog Posts: 0 0 0 0
 
 
 
Source: Globes Online

Niš :: Serbia | updated 2012-01-22 21:44:23 -0800 | business-news

The company reported a valuation gain on its assets of $175.4 million for the third quarter, compared with zero for the corresponding quarter. Revenue tripled to $34.8 million, including $34.6 million in rental income, for the third quarter, from $11.1...
Credibility  
Views: 5   News Stories: 5
Blog Posts: 0 0 0 0
 
 
Source: Globes Online

Niš :: Serbia | updated 2012-01-20 21:50:35 -0800 | business-news

NIS 60m for tissue regeneration initiative The British Israel Research and Academic Exchange Partnership will raise capital for the Regenerative Medicine Initiative that will invest in 15 projects. NIS 60 million over five years for the Regenerative Medicine Initiative that...
Credibility  
Views: 5   News Stories: 1
Blog Posts: 0 0 0 0
 
 
Source: Globes Online

Niš :: Serbia | updated 2012-01-13 14:15:52 -0800 | business-news

S A US appeals court allows Watson Pharmaceutical to sell a generic version of Teva's Seasonique birth-control pill. WPI) sales of a generic version of the Seasonique birth-control pill. The US Court of Appeals for the Federal Circuit in Washington...
Credibility  
Views: 47   News Stories: 5
Blog Posts: 0 0 0 0
 
 
Source: Globes Online

Niš :: Serbia | updated 2011-11-15 22:45:42 -0800 | travel-news

The trial in hemophilic mice compared Prolor's CTP modified version of Factor VIIa with commercial versions of recombinant Factor VIIa. Prolor's Factor VIIa-CTP showed a significantly longer half-life and duration of clotting activity compared with the commercial drug.
Credibility  
Views: 37   News Stories: 1
Blog Posts: 0 0 0 0
 

Build Your Allvoices Brand. Gain Influence. Make Money.

Join the Build Your Allvoices Brand Incentive Program



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.